PROBIOMED , S . A . DE C . V .
“ Biotech medicine will keep growing , it ’ s the promise of personalized medicine ”
– Sandra Sánchez- Oldenhage , CEO for PROBIOMED
Use of advanced equipment and devices demands constant training with the latestgeneration technology . PROBIOMED partners with different institutions to provide advanced training ; consequently , PROBIOMED offers a trainee program , which functioned as the company ’ s first contact with a group of now senior staff members .
“ We invest to develop better specialists and also to develop better individuals ,” Sánchez said .
Medical products where most needed
PROBIOMED already exports its valuable products globally . This fulfills obvious business goals , but perhaps more importantly , it also makes products available in emerging economies , treating the most possible patients at a low cost . Third-world countries are some of the most in need of the company ’ s biosimilar medical products .
Part of PROBIOMED ’ s portfolio is currently available in Guatemala , El Salvador , Honduras , Dominican Republic , Bolivia and Paraguay . Work is underway to get some of these products to Colombia , Brazil , Costa Rica , Chile and Ecuador as well . Ukraine , Kazakhstan , Pakistan and Argelia already benefit from the company ’ s biosimilar drugs , while Eastern Europe and other Asian and African countries are on
90 March 2016